ingenol mebutate gel 0.015%

DRUG2 trials

Sponsors

Korea University, University of California, San Francisco

Conditions

Actinic Keratosis

Phase 4

Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis

CompletedNCT02716714

Korea UniversityActinic Keratosis

Start: 2015-04-30End: 2016-06-30Updated: 2018-04-18

Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients

CompletedNCT02866695

University of California, San FranciscoActinic Keratosis

Start: 2016-10-06End: 2018-07-02Updated: 2022-03-09

Related Papers

A multicentre, open, investigator-initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0·015% on the face and scalp, and 0·05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT).

2018-05-145 citations